Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy. - Wikidata - awgldk - TriplyDB

Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.

Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.

http://www.wikidata.org/entity/Q37360457

about

Angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT1 The vasohibin family: a novel family for angiogenesis regulation Urinary and plasma levels of vasohibin-1 can predict renal functional deterioration in patients with renal disorders.Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice.Angiogenesis and chronic kidney disease.Suppression of adiponectin by aberrantly glycosylated IgA1 in glomerular mesangial cells in vitro and in vivo.Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.Vasohibin-1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstruction Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats.Age-related variations in the methylome associated with gene expression in human monocytes and T cells Transcriptome sequencing reveals differences between primary and secondary hair follicle-derived dermal papilla cells of the Cashmere goat (Capra hircus).Resveratrol attenuates diabetic nephropathy via modulating angiogenesis.Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways.Diabetic angiopathy and angiogenic defects.The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.Pathophysiology of the diabetic kidney.Vasohibin-1 expression is regulated by transforming growth factor-β/bone morphogenic protein signaling pathway between tumor-associated macrophages and pancreatic cancer cells.Vasohibin-1 and vasohibin-2 expression in gastric cancer cells and TAMs.Reduced expression of vasohibin-1 is associated with clinicopathological features in renal cell carcinoma.The effects of anti-inflammatory and anti-angiogenic DNA vaccination on diabetic nephropathy in rats.Antiangiogenic Therapy for Diabetic Nephropathy.Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy.Double-Face of Vasohibin-1 for the Maintenance of Vascular Homeostasis and Healthy Longevity.Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.Expression of vasohibin-1 and -2 predicts poor prognosis among patients with squamous cell carcinoma of the esophagus

P2860

Q24300671-05FF57B9-D1B4-4977-B6C8-28D99089CEB3 Q27013978-FDA33E01-03FB-4025-A787-2F9690C7B490 Q33733979-B754BC6D-73F7-473D-9E22-5AF9E0507871 Q33802812-6345BDDA-3683-4045-BE10-FA801C306965 Q34075013-98E9D50A-0511-4718-A1EC-BC98D869DBCE Q34212088-6242556F-2CCF-4305-916D-6DEF2793C0DF Q34257934-4710729C-C4CF-4ED5-B13E-A07E95B1CCA0 Q34399941-79CC4839-14F7-496E-AD19-D1AAA9E21D18 Q34441673-24DDD78A-7E22-4C88-BDB9-F2AEC6D6A8C3 Q34794642-AD312E0F-0246-4DA4-9FD2-178A41B4C7AB Q34999770-8BBB7719-590F-4BEC-A23F-BEC668CBF5AD Q35061522-723CBE66-6D63-4520-9030-A351E8FF78DC Q35299817-D8069032-1692-400B-9932-E06638AA3FBC Q36301365-6ECC355B-2FFD-49A5-8D24-53934BFDF352 Q36335626-70F4474C-28A8-4F4E-B5E2-249873C86420 Q38111707-2792E480-62EA-4139-B79A-DF49935E1C13 Q39155197-947423E6-6DC0-4266-9939-4E4536B3AAB2 Q39375805-907BC4C0-12C5-43E6-8967-A41415CA122A Q39574165-8ABD36C6-57C2-46E0-8C70-F3BD933BB84C Q41042820-35077DBE-B2AD-46F9-9073-B25CCD358C4B Q41403094-526BCF69-0DCB-4462-8F20-8C3A3F87C9A3 Q46616439-A974117B-E0FA-4B04-A13B-6E7B5A81904D Q49339334-C84D14FC-7118-4442-B461-7196E9E0B024 Q52594144-B15C5F3B-1837-4F86-8FD7-98275DD8DEEF Q58804278-21B439A9-3C16-4406-ABB1-8B27B2CCB450

P2860

Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.

http://www.wikidata.org/entity/Q37360457

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Vasohibin-1, a negative feedba ...... model of diabetic nephropathy.

@en

Vasohibin-1, a negative feedba ...... model of diabetic nephropathy.

@nl

type

label

Vasohibin-1, a negative feedba ...... model of diabetic nephropathy.

@en

Vasohibin-1, a negative feedba ...... model of diabetic nephropathy.

@nl

prefLabel

Vasohibin-1, a negative feedba ...... model of diabetic nephropathy.

@en

Vasohibin-1, a negative feedba ...... model of diabetic nephropathy.

@nl

P1433

Q37360457-52BA95EF-F45E-4466-A85A-85F28C130508

P1476

Q37360457-EBE01D7E-0407-4D3F-8F3A-58AB22582D27

P2093

Q37360457-00C331BA-31EC-444C-A4FF-366619602411

Q37360457-15E6C14D-C022-4038-A826-9A8D21835267

Q37360457-1BC8FE2A-F1AA-42E7-9608-D79D23032F93

Q37360457-4E54F430-6FA8-434F-8F2C-89E618100561

Q37360457-8BA422D3-3780-4AD9-8CBD-5A71D115DAFC

Q37360457-9C69FCF0-B801-4C79-9F56-F1E288EFB4FA

Q37360457-D1E0628D-F469-478E-B3B5-1E1EB105208F

Q37360457-E5BAD2D9-19D2-4B08-AF3A-6B3EFE246041

Q37360457-F97DE89D-4C3E-4822-A607-26DAA49A2D6C

P2860

Q37360457-0123CDCC-3565-4B5E-A9C8-E01DCB9B05B7

Q37360457-1F8DCED3-65A3-4095-89C2-542722B9C9FE

Q37360457-1FB09468-90FB-420B-99F9-387A19383134

Q37360457-2DC97951-70DB-4584-830E-A14D21DCD750

Q37360457-377054C6-5860-4E7F-8E61-F78392588A95

Q37360457-3B168E1F-B327-4EA0-953A-A774E59B1B65

Q37360457-3BDFB9EC-B327-4750-A06E-127D4D1D1B37

Q37360457-3C208F90-1386-4B9C-9840-DE32D05209D4

Q37360457-4A964E89-4A93-4D2D-990D-E22C518CE038

Q37360457-581E2202-8DEA-448E-9BCD-57ECFC006C9D

P304

Q37360457-B3C3ABFF-7926-48D9-95DF-BCC88A658B51

P31

Q37360457-EEAFB2CE-4BD8-4ECE-8639-05C4CF95280F

P356

Q37360457-887E2187-B5D4-4848-9210-42349CB60A22

P407

Q37360457-0DDDF957-6DF3-433B-A7C0-C2A486EDEA3D

P433

Q37360457-CF1E9935-5589-48CF-81F3-9FCFEE6DA9FC

P478

Q37360457-59ABF1A3-437D-470F-8751-6BA2DB521EE2

P577

Q37360457-4E105EBF-3EF9-457A-BFA9-CE9AB12D0128

P5875

Q37360457-76CFF18C-7EC2-49F6-A2BA-6820895050ED

P698

Q37360457-10716587-0392-4A2E-B064-D26795CE777C

P932

Q37360457-084D6179-C95C-46A0-997C-FE428B9F250A

P356

P1433

P1476

Vasohibin-1, a negative feedba ...... model of diabetic nephropathy.

@en

P2093

Hikaru Sonoda

http://www.w3.org/2001/XMLSchema#string

Hirofumi Makino

http://www.w3.org/2001/XMLSchema#string

Hitoshi Sugiyama

http://www.w3.org/2001/XMLSchema#string

Katsuyuki Tanabe

http://www.w3.org/2001/XMLSchema#string

Kumiko Hirokoshi-Kawahara

http://www.w3.org/2001/XMLSchema#string

Masaru Kinomura

http://www.w3.org/2001/XMLSchema#string

Tatsuyo Nasu

http://www.w3.org/2001/XMLSchema#string

Yasufumi Sato

http://www.w3.org/2001/XMLSchema#string

Yohei Maeshima

http://www.w3.org/2001/XMLSchema#string

P2860

Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis

Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis

VEGF inhibition and renal thrombotic microangiopathy

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

Vasohibin prevents arterial neointimal formation through angiogenesis inhibition

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

Angiogenesis in cancer, vascular, rheumatoid and other disease

Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

Vascular endothelial growth factor and the regulation of angiogenesis.

P304

2365-2375

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB08-1790

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26656581

http://www.w3.org/2001/XMLSchema#string

P698

19587360

http://www.w3.org/2001/XMLSchema#string

P932

2750227

http://www.w3.org/2001/XMLSchema#string